Philips Respironics has recalled certain V60 and V60 Plus ventilators because some of them could stop working due to an expired adhesive, the Food and Drug Administration announced this week. FDA has identified this as a Class 1 recall, the most serious type because it may cause serious injury or death. No injuries or adverse health consequences have been reported. 

In other news, Adamis Pharmaceuticals Corp. has recalled certain lots of epinephrine injection, an emergency treatment for allergic reactions, because the needle may clog and prevent the drug from dispensing. Health care providers may report associated adverse reactions or quality problems to the FDA's MedWatch program.

Related News Articles

Headline
The Food and Drug Administration yesterday revised its emergency use authorizations for all COVID-19 antigen tests to authorize serial testing and require…
Headline
Exela Pharma Sciences this week recalled 49 lots of sodium bicarbonate injection because the vial may break while preparing the product for administration…
Headline
Philips Respironics has recalled more than 17 million masks used with Bilevel Positive Airway Pressure and Continuous Positive Airway Pressure machines because…
Headline
The Food and Drug Administration today announced a Class 1 recall of devices used to access blood vessels through a patient’s bone because the devices may…
Headline
The Environmental Protection Agency today released a list of commercial medical device sterilizing facilities where lifetime risk from ethylene oxide emissions…
Headline
Baxter Healthcare Corp. recently recalled its Abacus software for ordering compounded liquid medications due to a risk the printed bag labels may contain…